Literature DB >> 26564810

Idiopathic non-specific interstitial pneumonia.

Elizabeth A Belloli1, Rosemarie Beckford1, Ryan Hadley1, Kevin R Flaherty1.   

Abstract

Non-specific interstitial pneumonia (NSIP) is an interstitial lung disease that may be idiopathic or secondary to connective tissue disease, toxins or numerous other causes. Idiopathic NSIP is a rare diagnosis and requires exclusion of these other possible causes. Patients typically present in mid-adulthood with dyspnoea, cough and often constitutional symptoms including fever and fatigue. The disease has a female predominance, and more than 50% of patients have never smoked. Physical exam features mild hypoxaemia and inspiratory rales. Pulmonary function tests demonstrate restriction and a low diffusing capacity for carbon monoxide. High-resolution computed tomography abnormalities include predominantly lower lobe subpleural reticular changes, traction bronchiectasis and ground-glass opacities; honeycombing is rarely seen. An evaluation of the underlying pathology is necessary for a firm diagnosis. Histologically, alveolar and interstitial mononuclear cell inflammation and fibrosis are seen in a temporally uniform pattern with preserved underlying alveolar architecture. NSIP must be differentiated from other parenchymal lung diseases including idiopathic pulmonary fibrosis and hypersensitivity pneumonitis. A thorough exposure history and assessment for underlying connective tissue diseases are highly important, as positive findings in these categories would likely denote a case of secondary NSIP. A multi-disciplinary discussion that includes pulmonologist(s), radiologist(s) and pathologist(s) assists in reaching a consensus diagnosis and improves diagnostic accuracy. Treatment of idiopathic NSIP, although not well proven, is generally instituted in the form of immunosuppression. Prognosis is favourable compared with idiopathic pulmonary fibrosis, although the diagnosis still carries an attributable mortality. Herein we will summarize the clinical characteristics and management of idiopathic NSIP.
© 2015 Asian Pacific Society of Respirology.

Entities:  

Keywords:  connective tissue disease; idiopathic interstitial pneumonia; interstitial lung disease; non-specific interstitial pneumonia

Mesh:

Year:  2015        PMID: 26564810     DOI: 10.1111/resp.12674

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  12 in total

1.  Central paradiaphragmatic middle lobe involvement in nonspecific interstitial pneumonia.

Authors:  Joanna G Escalon; Alan C Legasto; Dennis Toy; James F Gruden
Journal:  Eur Radiol       Date:  2021-02-23       Impact factor: 5.315

2.  The effectiveness of immunosuppressive cyclosporin in attenuating the progression of interstitial lung diseases.

Authors:  Mathew Suji Eapen; Archana Vijay Gaikwad; Isobel E Thompson; Wenying Lu; Stephen Myers; Pawan Sharma; Sukhwinder Singh Sohal
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

3.  Comprehensive gene expression profiling identifies distinct and overlapping transcriptional profiles in non-specific interstitial pneumonia and idiopathic pulmonary fibrosis.

Authors:  Matthew J Cecchini; Karishma Hosein; Christopher J Howlett; Mariamma Joseph; Marco Mura
Journal:  Respir Res       Date:  2018-08-15

Review 4.  Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 3. Idiopathic Nonspecific Interstitial Pneumonia.

Authors:  Jongmin Lee; Yong Hyun Kim; Ji Young Kang; Yangjin Jegal; So Young Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2019-05-31

Review 5.  Management of Fibrosing Interstitial Lung Diseases.

Authors:  Toby M Maher; Wim Wuyts
Journal:  Adv Ther       Date:  2019-05-22       Impact factor: 3.845

6.  Morphological and molecular motifs of fibrosing pulmonary injury patterns.

Authors:  Danny Jonigk; Helge Stark; Peter Braubach; Lavinia Neubert; Hoen-Oh Shin; Nicole Izykowski; Tobias Welte; Sabina Janciauskiene; Gregor Warnecke; Axel Haverich; Mark Kuehnel; Florian Laenger
Journal:  J Pathol Clin Res       Date:  2019-09-25

7.  Discrimination between NSIP- and IPF-Derived Fibroblasts Based on Multi-Parameter Characterization of Their Growth, Morphology and Physic-Chemical Properties.

Authors:  Barbara Orzechowska; Kamil Awsiuk; Dawid Wnuk; Joanna Pabijan; Tomasz Stachura; Jerzy Soja; Krzysztof Sładek; Joanna Raczkowska
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 5.923

Review 8.  High incidence and early onset of nivolumab-induced pneumonitis: four case reports and literature review.

Authors:  N Koyama; O Iwase; E Nakashima; K Kishida; T Kondo; Y Watanabe; H Takahashi; Y Umebayashi; Y Ogawa; H Miura
Journal:  BMC Pulm Med       Date:  2018-01-30       Impact factor: 3.317

9.  Factors affecting treatment outcome in patients with idiopathic nonspecific interstitial pneumonia: a nationwide cohort study.

Authors:  Sang Hoon Lee; Moo Suk Park; Song Yee Kim; Dong Soon Kim; Young Whan Kim; Man Pyo Chung; Soo Taek Uh; Choon Sik Park; Sung Woo Park; Sung Hwan Jeong; Yong Bum Park; Hong Lyeol Lee; Jong Wook Shin; Eun Joo Lee; Jin Hwa Lee; Yangin Jegal; Hyun Kyung Lee; Yong Hyun Kim; Jin Woo Song; Jong Sun Park
Journal:  Respir Res       Date:  2017-12-06

10.  Value of Cardiopulmonary Exercise Testing in Prognostic Assessment of Patients with Interstitial Lung Diseases.

Authors:  Beate Stubbe; Till Ittermann; Anita Grieger; Charlotte Walther; Sven Gläser; Ralf Ewert
Journal:  J Clin Med       Date:  2022-03-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.